- Home
- ATLO vs CGTX Comparison
ATLO vs CGTX Comparison
Compare ATLO & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- CGTX
- Stock Information
- Founded
- ATLO 1903
- CGTX 2007
- Country
- ATLO United States
- CGTX United States
- Employees
- ATLO N/A
- CGTX N/A
- Industry
- ATLO Major Banks
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATLO Finance
- CGTX Health Care
- Exchange
- ATLO Nasdaq
- CGTX Nasdaq
- Market Cap
- ATLO 187.5M
- CGTX 158.8M
- IPO Year
- ATLO N/A
- CGTX 2021
- Fundamental
- Price
- ATLO $21.10
- CGTX $1.51
- Analyst Decision
- ATLO
- CGTX Strong Buy
- Analyst Count
- ATLO 0
- CGTX 3
- Target Price
- ATLO N/A
- CGTX $2.83
- AVG Volume (30 Days)
- ATLO 21.9K
- CGTX 1.1M
- Earning Date
- ATLO 10-17-2025
- CGTX 11-06-2025
- Dividend Yield
- ATLO 3.83%
- CGTX N/A
- EPS Growth
- ATLO 82.57
- CGTX N/A
- EPS
- ATLO 1.80
- CGTX N/A
- Revenue
- ATLO $60,568,000.00
- CGTX N/A
- Revenue This Year
- ATLO N/A
- CGTX N/A
- Revenue Next Year
- ATLO N/A
- CGTX N/A
- P/E Ratio
- ATLO $11.64
- CGTX N/A
- Revenue Growth
- ATLO 18.60
- CGTX N/A
- 52 Week Low
- ATLO $15.75
- CGTX $0.22
- 52 Week High
- ATLO $21.48
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- ATLO 57.20
- CGTX 42.27
- Support Level
- ATLO $20.51
- CGTX $1.46
- Resistance Level
- ATLO $21.47
- CGTX $1.83
- Average True Range (ATR)
- ATLO 0.32
- CGTX 0.13
- MACD
- ATLO -0.03
- CGTX -0.02
- Stochastic Oscillator
- ATLO 78.46
- CGTX 25.93
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.